Table of Content

1 Study Coverage
1.1 VISTA Antibody Product Introduction
1.2 Market by Type
1.2.1 Global VISTA Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global VISTA Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global VISTA Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global VISTA Antibody Revenue by Region
2.2.1 Global VISTA Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global VISTA Antibody Revenue by Region (2018-2024)
2.2.3 Global VISTA Antibody Revenue by Region (2024-2029)
2.2.4 Global VISTA Antibody Revenue Market Share by Region (2018-2029)
2.3 Global VISTA Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global VISTA Antibody Sales by Region
2.4.1 Global VISTA Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global VISTA Antibody Sales by Region (2018-2024)
2.4.3 Global VISTA Antibody Sales by Region (2024-2029)
2.4.4 Global VISTA Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global VISTA Antibody Sales by Manufacturers
3.1.1 Global VISTA Antibody Sales by Manufacturers (2018-2024)
3.1.2 Global VISTA Antibody Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of VISTA Antibody in 2022
3.2 Global VISTA Antibody Revenue by Manufacturers
3.2.1 Global VISTA Antibody Revenue by Manufacturers (2018-2024)
3.2.2 Global VISTA Antibody Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by VISTA Antibody Revenue in 2022
3.3 Global Key Players of VISTA Antibody, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global VISTA Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global VISTA Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of VISTA Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of VISTA Antibody, Product Offered and Application
3.8 Global Key Manufacturers of VISTA Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global VISTA Antibody Sales by Type
4.1.1 Global VISTA Antibody Historical Sales by Type (2018-2024)
4.1.2 Global VISTA Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global VISTA Antibody Sales Market Share by Type (2018-2029)
4.2 Global VISTA Antibody Revenue by Type
4.2.1 Global VISTA Antibody Historical Revenue by Type (2018-2024)
4.2.2 Global VISTA Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global VISTA Antibody Revenue Market Share by Type (2018-2029)
4.3 Global VISTA Antibody Price by Type
4.3.1 Global VISTA Antibody Price by Type (2018-2024)
4.3.2 Global VISTA Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global VISTA Antibody Sales by Application
5.1.1 Global VISTA Antibody Historical Sales by Application (2018-2024)
5.1.2 Global VISTA Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global VISTA Antibody Sales Market Share by Application (2018-2029)
5.2 Global VISTA Antibody Revenue by Application
5.2.1 Global VISTA Antibody Historical Revenue by Application (2018-2024)
5.2.2 Global VISTA Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global VISTA Antibody Revenue Market Share by Application (2018-2029)
5.3 Global VISTA Antibody Price by Application
5.3.1 Global VISTA Antibody Price by Application (2018-2024)
5.3.2 Global VISTA Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada VISTA Antibody Market Size by Type
6.1.1 US & Canada VISTA Antibody Sales by Type (2018-2029)
6.1.2 US & Canada VISTA Antibody Revenue by Type (2018-2029)
6.2 US & Canada VISTA Antibody Market Size by Application
6.2.1 US & Canada VISTA Antibody Sales by Application (2018-2029)
6.2.2 US & Canada VISTA Antibody Revenue by Application (2018-2029)
6.3 US & Canada VISTA Antibody Market Size by Country
6.3.1 US & Canada VISTA Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada VISTA Antibody Sales by Country (2018-2029)
6.3.3 US & Canada VISTA Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe VISTA Antibody Market Size by Type
7.1.1 Europe VISTA Antibody Sales by Type (2018-2029)
7.1.2 Europe VISTA Antibody Revenue by Type (2018-2029)
7.2 Europe VISTA Antibody Market Size by Application
7.2.1 Europe VISTA Antibody Sales by Application (2018-2029)
7.2.2 Europe VISTA Antibody Revenue by Application (2018-2029)
7.3 Europe VISTA Antibody Market Size by Country
7.3.1 Europe VISTA Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe VISTA Antibody Sales by Country (2018-2029)
7.3.3 Europe VISTA Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China VISTA Antibody Market Size
8.1.1 China VISTA Antibody Sales (2018-2029)
8.1.2 China VISTA Antibody Revenue (2018-2029)
8.2 China VISTA Antibody Market Size by Application
8.2.1 China VISTA Antibody Sales by Application (2018-2029)
8.2.2 China VISTA Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia VISTA Antibody Market Size by Type
9.1.1 Asia VISTA Antibody Sales by Type (2018-2029)
9.1.2 Asia VISTA Antibody Revenue by Type (2018-2029)
9.2 Asia VISTA Antibody Market Size by Application
9.2.1 Asia VISTA Antibody Sales by Application (2018-2029)
9.2.2 Asia VISTA Antibody Revenue by Application (2018-2029)
9.3 Asia VISTA Antibody Sales by Region
9.3.1 Asia VISTA Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia VISTA Antibody Revenue by Region (2018-2029)
9.3.3 Asia VISTA Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America VISTA Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America VISTA Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America VISTA Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America VISTA Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America VISTA Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America VISTA Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America VISTA Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America VISTA Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America VISTA Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America VISTA Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Information
11.1.2 Sino Biological, Inc. Overview
11.1.3 Sino Biological, Inc. VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sino Biological, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sino Biological, Inc. Recent Developments
11.2 Abcam
11.2.1 Abcam Company Information
11.2.2 Abcam Overview
11.2.3 Abcam VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Abcam VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abcam Recent Developments
11.3 RayBiotech, Inc.
11.3.1 RayBiotech, Inc. Company Information
11.3.2 RayBiotech, Inc. Overview
11.3.3 RayBiotech, Inc. VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 RayBiotech, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 RayBiotech, Inc. Recent Developments
11.4 MyBiosource, Inc.
11.4.1 MyBiosource, Inc. Company Information
11.4.2 MyBiosource, Inc. Overview
11.4.3 MyBiosource, Inc. VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 MyBiosource, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MyBiosource, Inc. Recent Developments
11.5 LifeSpan BioSciences, Inc
11.5.1 LifeSpan BioSciences, Inc Company Information
11.5.2 LifeSpan BioSciences, Inc Overview
11.5.3 LifeSpan BioSciences, Inc VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 LifeSpan BioSciences, Inc VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LifeSpan BioSciences, Inc Recent Developments
11.6 Arigo Biolaboratories Corp.
11.6.1 Arigo Biolaboratories Corp. Company Information
11.6.2 Arigo Biolaboratories Corp. Overview
11.6.3 Arigo Biolaboratories Corp. VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Arigo Biolaboratories Corp. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Arigo Biolaboratories Corp. Recent Developments
11.7 GeneTex
11.7.1 GeneTex Company Information
11.7.2 GeneTex Overview
11.7.3 GeneTex VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GeneTex VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GeneTex Recent Developments
11.8 Biorbyt
11.8.1 Biorbyt Company Information
11.8.2 Biorbyt Overview
11.8.3 Biorbyt VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biorbyt VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biorbyt Recent Developments
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Information
11.9.2 Creative Biolabs Overview
11.9.3 Creative Biolabs VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Creative Biolabs VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Creative Biolabs Recent Developments
11.10 Assay Genie
11.10.1 Assay Genie Company Information
11.10.2 Assay Genie Overview
11.10.3 Assay Genie VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Assay Genie VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Assay Genie Recent Developments
11.11 Cell Signaling Technology, Inc.
11.11.1 Cell Signaling Technology, Inc. Company Information
11.11.2 Cell Signaling Technology, Inc. Overview
11.11.3 Cell Signaling Technology, Inc. VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Cell Signaling Technology, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cell Signaling Technology, Inc. Recent Developments
11.12 Bio-Techne
11.12.1 Bio-Techne Company Information
11.12.2 Bio-Techne Overview
11.12.3 Bio-Techne VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Bio-Techne VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bio-Techne Recent Developments
11.13 Abbexa
11.13.1 Abbexa Company Information
11.13.2 Abbexa Overview
11.13.3 Abbexa VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Abbexa VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Abbexa Recent Developments
11.14 OriGene Technologies, Inc.
11.14.1 OriGene Technologies, Inc. Company Information
11.14.2 OriGene Technologies, Inc. Overview
11.14.3 OriGene Technologies, Inc. VISTA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 OriGene Technologies, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 OriGene Technologies, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 VISTA Antibody Industry Chain Analysis
12.2 VISTA Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 VISTA Antibody Production Mode & Process
12.4 VISTA Antibody Sales and Marketing
12.4.1 VISTA Antibody Sales Channels
12.4.2 VISTA Antibody Distributors
12.5 VISTA Antibody Customers
13 Market Dynamics
13.1 VISTA Antibody Industry Trends
13.2 VISTA Antibody Market Drivers
13.3 VISTA Antibody Market Challenges
13.4 VISTA Antibody Market Restraints
14 Key Findings in The Global VISTA Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global VISTA Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Polyclonal Antibody
Table 4. Global VISTA Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global VISTA Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global VISTA Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global VISTA Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global VISTA Antibody Revenue Market Share by Region (2018-2024)
Table 9. Global VISTA Antibody Revenue Market Share by Region (2024-2029)
Table 10. Global VISTA Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global VISTA Antibody Sales by Region (2018-2024) & (K Units)
Table 12. Global VISTA Antibody Sales by Region (2024-2029) & (K Units)
Table 13. Global VISTA Antibody Sales Market Share by Region (2018-2024)
Table 14. Global VISTA Antibody Sales Market Share by Region (2024-2029)
Table 15. Global VISTA Antibody Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global VISTA Antibody Sales Share by Manufacturers (2018-2024)
Table 17. Global VISTA Antibody Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global VISTA Antibody Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of VISTA Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. VISTA Antibody Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global VISTA Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global VISTA Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VISTA Antibody as of 2022)
Table 23. Global Key Manufacturers of VISTA Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of VISTA Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of VISTA Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global VISTA Antibody Sales by Type (2018-2024) & (K Units)
Table 28. Global VISTA Antibody Sales by Type (2024-2029) & (K Units)
Table 29. Global VISTA Antibody Sales Share by Type (2018-2024)
Table 30. Global VISTA Antibody Sales Share by Type (2024-2029)
Table 31. Global VISTA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global VISTA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global VISTA Antibody Revenue Share by Type (2018-2024)
Table 34. Global VISTA Antibody Revenue Share by Type (2024-2029)
Table 35. VISTA Antibody Price by Type (2018-2024) & (US$/Unit)
Table 36. Global VISTA Antibody Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global VISTA Antibody Sales by Application (2018-2024) & (K Units)
Table 38. Global VISTA Antibody Sales by Application (2024-2029) & (K Units)
Table 39. Global VISTA Antibody Sales Share by Application (2018-2024)
Table 40. Global VISTA Antibody Sales Share by Application (2024-2029)
Table 41. Global VISTA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global VISTA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global VISTA Antibody Revenue Share by Application (2018-2024)
Table 44. Global VISTA Antibody Revenue Share by Application (2024-2029)
Table 45. VISTA Antibody Price by Application (2018-2024) & (US$/Unit)
Table 46. Global VISTA Antibody Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada VISTA Antibody Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada VISTA Antibody Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada VISTA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada VISTA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada VISTA Antibody Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada VISTA Antibody Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada VISTA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada VISTA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada VISTA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada VISTA Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada VISTA Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada VISTA Antibody Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada VISTA Antibody Sales by Country (2024-2029) & (K Units)
Table 60. Europe VISTA Antibody Sales by Type (2018-2024) & (K Units)
Table 61. Europe VISTA Antibody Sales by Type (2024-2029) & (K Units)
Table 62. Europe VISTA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe VISTA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe VISTA Antibody Sales by Application (2018-2024) & (K Units)
Table 65. Europe VISTA Antibody Sales by Application (2024-2029) & (K Units)
Table 66. Europe VISTA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe VISTA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe VISTA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe VISTA Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe VISTA Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe VISTA Antibody Sales by Country (2018-2024) & (K Units)
Table 72. Europe VISTA Antibody Sales by Country (2024-2029) & (K Units)
Table 73. China VISTA Antibody Sales by Type (2018-2024) & (K Units)
Table 74. China VISTA Antibody Sales by Type (2024-2029) & (K Units)
Table 75. China VISTA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 76. China VISTA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 77. China VISTA Antibody Sales by Application (2018-2024) & (K Units)
Table 78. China VISTA Antibody Sales by Application (2024-2029) & (K Units)
Table 79. China VISTA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 80. China VISTA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia VISTA Antibody Sales by Type (2018-2024) & (K Units)
Table 82. Asia VISTA Antibody Sales by Type (2024-2029) & (K Units)
Table 83. Asia VISTA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia VISTA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia VISTA Antibody Sales by Application (2018-2024) & (K Units)
Table 86. Asia VISTA Antibody Sales by Application (2024-2029) & (K Units)
Table 87. Asia VISTA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia VISTA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia VISTA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia VISTA Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia VISTA Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia VISTA Antibody Sales by Region (2018-2024) & (K Units)
Table 93. Asia VISTA Antibody Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America VISTA Antibody Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America VISTA Antibody Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America VISTA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America VISTA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America VISTA Antibody Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America VISTA Antibody Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America VISTA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America VISTA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America VISTA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America VISTA Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America VISTA Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America VISTA Antibody Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America VISTA Antibody Sales by Country (2024-2029) & (K Units)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Description and Major Businesses
Table 109. Sino Biological, Inc. VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sino Biological, Inc. Recent Developments
Table 112. Abcam Company Information
Table 113. Abcam Description and Major Businesses
Table 114. Abcam VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Abcam VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Abcam Recent Developments
Table 117. RayBiotech, Inc. Company Information
Table 118. RayBiotech, Inc. Description and Major Businesses
Table 119. RayBiotech, Inc. VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. RayBiotech, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. RayBiotech, Inc. Recent Developments
Table 122. MyBiosource, Inc. Company Information
Table 123. MyBiosource, Inc. Description and Major Businesses
Table 124. MyBiosource, Inc. VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. MyBiosource, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MyBiosource, Inc. Recent Developments
Table 127. LifeSpan BioSciences, Inc Company Information
Table 128. LifeSpan BioSciences, Inc Description and Major Businesses
Table 129. LifeSpan BioSciences, Inc VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. LifeSpan BioSciences, Inc VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. LifeSpan BioSciences, Inc Recent Developments
Table 132. Arigo Biolaboratories Corp. Company Information
Table 133. Arigo Biolaboratories Corp. Description and Major Businesses
Table 134. Arigo Biolaboratories Corp. VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Arigo Biolaboratories Corp. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Arigo Biolaboratories Corp. Recent Developments
Table 137. GeneTex Company Information
Table 138. GeneTex Description and Major Businesses
Table 139. GeneTex VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. GeneTex VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. GeneTex Recent Developments
Table 142. Biorbyt Company Information
Table 143. Biorbyt Description and Major Businesses
Table 144. Biorbyt VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biorbyt VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biorbyt Recent Developments
Table 147. Creative Biolabs Company Information
Table 148. Creative Biolabs Description and Major Businesses
Table 149. Creative Biolabs VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Creative Biolabs VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Creative Biolabs Recent Developments
Table 152. Assay Genie Company Information
Table 153. Assay Genie Description and Major Businesses
Table 154. Assay Genie VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Assay Genie VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Assay Genie Recent Developments
Table 157. Cell Signaling Technology, Inc. Company Information
Table 158. Cell Signaling Technology, Inc. Description and Major Businesses
Table 159. Cell Signaling Technology, Inc. VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Cell Signaling Technology, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Cell Signaling Technology, Inc. Recent Developments
Table 162. Bio-Techne Company Information
Table 163. Bio-Techne Description and Major Businesses
Table 164. Bio-Techne VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Bio-Techne VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Bio-Techne Recent Developments
Table 167. Abbexa Company Information
Table 168. Abbexa Description and Major Businesses
Table 169. Abbexa VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Abbexa VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Abbexa Recent Developments
Table 172. OriGene Technologies, Inc. Company Information
Table 173. OriGene Technologies, Inc. Description and Major Businesses
Table 174. OriGene Technologies, Inc. VISTA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. OriGene Technologies, Inc. VISTA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. OriGene Technologies, Inc. Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. VISTA Antibody Distributors List
Table 180. VISTA Antibody Customers List
Table 181. VISTA Antibody Market Trends
Table 182. VISTA Antibody Market Drivers
Table 183. VISTA Antibody Market Challenges
Table 184. VISTA Antibody Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. VISTA Antibody Product Picture
Figure 2. Global VISTA Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global VISTA Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global VISTA Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global VISTA Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. VISTA Antibody Report Years Considered
Figure 15. Global VISTA Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global VISTA Antibody Revenue 2018-2029 (US$ Million)
Figure 17. Global VISTA Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global VISTA Antibody Revenue Market Share by Region (2018-2029)
Figure 19. Global VISTA Antibody Sales 2018-2029 ((K Units)
Figure 20. Global VISTA Antibody Sales Market Share by Region (2018-2029)
Figure 21. US & Canada VISTA Antibody Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada VISTA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe VISTA Antibody Sales YoY (2018-2029) & (K Units)
Figure 24. Europe VISTA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China VISTA Antibody Sales YoY (2018-2029) & (K Units)
Figure 26. China VISTA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) VISTA Antibody Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) VISTA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America VISTA Antibody Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America VISTA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The VISTA Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of VISTA Antibody in the World: Market Share by VISTA Antibody Revenue in 2022
Figure 33. Global VISTA Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global VISTA Antibody Sales Market Share by Type (2018-2029)
Figure 35. Global VISTA Antibody Revenue Market Share by Type (2018-2029)
Figure 36. Global VISTA Antibody Sales Market Share by Application (2018-2029)
Figure 37. Global VISTA Antibody Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada VISTA Antibody Sales Market Share by Type (2018-2029)
Figure 39. US & Canada VISTA Antibody Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada VISTA Antibody Sales Market Share by Application (2018-2029)
Figure 41. US & Canada VISTA Antibody Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada VISTA Antibody Revenue Share by Country (2018-2029)
Figure 43. US & Canada VISTA Antibody Sales Share by Country (2018-2029)
Figure 44. U.S. VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 45. Canada VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 46. Europe VISTA Antibody Sales Market Share by Type (2018-2029)
Figure 47. Europe VISTA Antibody Revenue Market Share by Type (2018-2029)
Figure 48. Europe VISTA Antibody Sales Market Share by Application (2018-2029)
Figure 49. Europe VISTA Antibody Revenue Market Share by Application (2018-2029)
Figure 50. Europe VISTA Antibody Revenue Share by Country (2018-2029)
Figure 51. Europe VISTA Antibody Sales Share by Country (2018-2029)
Figure 52. Germany VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 53. France VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 55. Italy VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 56. Russia VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 57. China VISTA Antibody Sales Market Share by Type (2018-2029)
Figure 58. China VISTA Antibody Revenue Market Share by Type (2018-2029)
Figure 59. China VISTA Antibody Sales Market Share by Application (2018-2029)
Figure 60. China VISTA Antibody Revenue Market Share by Application (2018-2029)
Figure 61. Asia VISTA Antibody Sales Market Share by Type (2018-2029)
Figure 62. Asia VISTA Antibody Revenue Market Share by Type (2018-2029)
Figure 63. Asia VISTA Antibody Sales Market Share by Application (2018-2029)
Figure 64. Asia VISTA Antibody Revenue Market Share by Application (2018-2029)
Figure 65. Asia VISTA Antibody Revenue Share by Region (2018-2029)
Figure 66. Asia VISTA Antibody Sales Share by Region (2018-2029)
Figure 67. Japan VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 71. India VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America VISTA Antibody Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America VISTA Antibody Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America VISTA Antibody Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America VISTA Antibody Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America VISTA Antibody Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America VISTA Antibody Sales Share by Country (2018-2029)
Figure 78. Brazil VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 81. Israel VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries VISTA Antibody Revenue (2018-2029) & (US$ Million)
Figure 83. VISTA Antibody Value Chain
Figure 84. VISTA Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed